#BRECADD - Twitter Hashtag

4 months ago

#Hematology Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic #Hodgkin #lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial - ⁦@TheLancetHaem⁩ #lymsm #brentuximab #BRECADD https://t.co/A9u06aGosM

0

11

2

5

653

Ahmed Kotb @AhmedKo45911157

over 1 year ago

HD21: BrECADD vs escBEACOPP in Advanced HL Patients ≤60 yrs with stage IIB–IV PFS: BrECADD 94% vs eBEACOPP 91% HR: 0.66 (p = 0.035) Lower toxicity with BrECADD Brentuximab adds efficacy with better tolerability! #HodgkinLymphoma #BrECADD #BEACOPP #ILC7 #HL

AhmedKo45911157's tweet photo. HD21: BrECADD vs escBEACOPP in Advanced HL
Patients ≤60 yrs with stage IIB–IV

PFS:
BrECADD 94% vs eBEACOPP 91%

HR: 0.66 (p = 0.035)

Lower toxicity with BrECADD

Brentuximab adds efficacy with better tolerability!
#HodgkinLymphoma #BrECADD #BEACOPP #ILC7 #HL https://t.co/J8zKkwhDOg

0

2

1

542

Hematologia Althaia @HemAlthaia

over 2 years ago

PET2-Guided BrECADD Is Safer and More Effective Than Escalated BEACOPP in Adults With Advanced Classical Hodgkin Lymphoma @geltamo #hodgkinlymphoma #BrECADD #ASCO24

ASCO @ASCO

over 2 years ago

New from #ASCO24: The novel BrECADD regimen is better tolerated & more effective than escalated BEACOPP in adults w/ advanced cHL. Improved tolerability allows outpatient treatment, and most pts recover from TRAEs within 1 yr: https://t.co/V48CEUIl2i #ASCODailyNews #lymsm

ASCO's tweet photo. New from #ASCO24: The novel BrECADD regimen is better tolerated & more effective than escalated BEACOPP in adults w/ advanced cHL. Improved tolerability allows outpatient treatment, and most pts recover from TRAEs within 1 yr: https://t.co/V48CEUIl2i #ASCODailyNews #lymsm https://t.co/MFmuQ6QAnQ

0

10

2

4K

0

3

1

0

298

Top Tweets for #BRECADD

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users